Share price has suffered accordingly…..
Net revenue for the quarter ended June 30 was $9.9 million, a 17.9% increase over the previous quarter. Cronos reports in U.S. dollars.
About $2.2 million of that revenue came from Cronos’ U.S. operations, with the remainder coming from the “rest of world” business segment, which includes adult-use and medical sales in Canada and international interests in Australia, Colombia, Germany and Israel.
Read more at.
Canadian cannabis firm Cronos posts $31.3M operating loss in second quarter
